首页> 外文期刊>Human Genetics >Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.
【24h】

Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.

机译:细胞周期蛋白D1剪接变体和非霍奇金淋巴瘤的风险。

获取原文
获取原文并翻译 | 示例
       

摘要

To investigate the role of cell cycle gene variations in lymphomagenesis, we evaluated associations (odds ratios [OR] and 95% confidence intervals [CI]) in polymorphisms from seven candidate genes in 1,172 non-Hodgkin lymphoma (NHL) cases and 982 population-based controls. The cyclin D1 (CCND1) splice variant G870A (rs603965) increased NHL risk (OR(AA) = 1.4, 95% CI = 1.1-1.8, P-trend = 0.021), which was consistent for four B-cell subtypes. As CCND1 expression indicates poor NHL prognosis, our results, if true, would support its potentially dual importance in NHL etiology and survival.
机译:为了研究细胞周期基因变异在淋巴瘤发生中的作用,我们评估了1,172例非霍奇金淋巴瘤(NHL)病例和982位人群的7个候选基因的多态性之间的关联(奇数比[OR]和95%置信区间[CI])。基于控件。细胞周期蛋白D1(CCND1)剪接变体G870A(rs603965)增加了NHL风险(OR(AA)= 1.4,95%CI = 1.1-1.8,P-trend = 0.021),这与四种B细胞亚型一致。由于CCND1表达表明NHL的预后不良,因此我们的结果(如果为真)将支持其在NHL病因和生存中的潜在双重重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号